Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.
Study #: LY22-02g
Study Status: Published
Epperla N, Hashmi H, Ahn KW, Chen AI, Wirk B, Kanakry JA, Lekakis L, Lekakis L, Kharfan-Dabaja MA, Scordo M, Riedell PA, Jain T, Shadman M, Sauter C, Hamadani M, Herrera AF, Ahmed S.
British Journal of Haematology. 2024, May 26: (): . doi: 10.1111/bjh.19569. Epub 2024, May 26. PMCID:.
PMID: 38797526
Abstract